After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a…
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
How I used psychology to come back from the worst year of my life
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
The distant world that is our best hope of finding alien life
5
Photos reveal unexpected details from the world's first atomic test
6
Epic dreaming is leaving people exhausted and distressed
7
The ‘doomsday’ glacier’s giant ice shelf is about to break away
8
Women’s better memories may delay Alzheimer’s diagnosis by years
9
The 3 things you need to know about protein, according to an expert
10
Mystery of the ancient giant stone jars of Laos may have been solved
